Articles in 2018

Filter By:

  • Hydrolysis of phosphatidylcholine to choline was found to be catalysed by phospholipase D enzymes from diverse members of the gut microbiota, revealing a mechanism by which commensals obtain choline for subsequent production of disease-associated trimethylamine.

    • Aaron T. Wright
    News & Views
  • APOBEC3 restriction, known to inhibit retroviruses by interfering with genome replication and hypermutating viral DNA, targets the γ-herpesvirus Epstein–Barr virus and is antagonized by the viral BORF2 protein.

    • Michael H. Malim
    • Darja Pollpeter
    News & Views
  • The early identification of repetitive genomic loci in Haloferax species was instrumental in igniting interest in CRISPR–Cas systems. Now, work in this genus has revealed an important role of CRISPR–Cas in reducing an unusual form of inter-species archaeal mating that occurs by cell fusion.

    • Peter C. Fineran
    News & Views
  • Streptococcus pneumoniae strains colonizing the nasopharynx use quorum sensing and fratricide to outcompete incoming strains, thereby retaining ownership of the host. This occurs via activation of the competence regulon, induction of lytic proteins, and turning the invader into a source of DNA for genetic exchange.

    • James C. Paton
    • Claudia Trappetti
    News & Views
  • Despite major advances in dissecting how pathogens cause disease and the development of treatments to combat infection, infectious diseases remain a major cause of death today. This month’s issue includes a special ‘Focus on Infectious Disease’, which highlights efforts to develop new ways to prevent, detect and treat infections.

    Editorial
  • This Review Article describes how recent advances in viral genome sequencing and phylogenetics have enabled key issues associated with outbreak epidemiology to be more accurately addressed, and highlights the requirements and challenges for generating, sharing and using such data when tackling a viral outbreak.

    • Nathan D. Grubaugh
    • Jason T. Ladner
    • Kristian G. Andersen
    Review Article
  • This Review discusses the role of the gut, respiratory tract and vaginal microbiota in susceptibility and resistance to infectious diseases.

    • Josie Libertucci
    • Vincent B. Young
    Review Article
  • The structure of enterovirus 71 in complex with its receptor SCARB2 provides insights into the mechanism of viral uncoating within the endo/lysosome compartment and identifies few conserved key residues within the binding footprint that might facilitate the design of receptor mimic therapeutics.

    • Daming Zhou
    • Yuguang Zhao
    • David I. Stuart
    Letter
  • Using metabolomics and shotgun metagenomics on stool samples from individuals with and without inflammatory bowel disease, metabolites, microbial species and genes associated with disease were identified and validated in an independent cohort.

    • Eric A. Franzosa
    • Alexandra Sirota-Madi
    • Ramnik J. Xavier
    Article
  • A bacterial strain that requires the neurotransmitter GABA for growth was identified and used to isolate GABA-producing bacteria, including Bacteroides spp., from human stool samples; the relative abundance of Bacteroides was negatively correlated with an altered GABA-mediated response in a depression patient cohort.

    • Philip Strandwitz
    • Ki Hyun Kim
    • Kim Lewis
    Letter
  • Two distinct pathways control inflammasome activation during Aspergillus fumigatus infection. The C-type lectin receptor (CLR) pathway activates MAPK and NF-κB signalling, whereas Toll-like receptor (TLR) signalling is activated through MyD88 and TRIF. Both pathways activate transcription factor IRF1, which induces antifungal effector IRGB10.

    • Benoit Briard
    • Rajendra Karki
    • Thirumala-Devi Kanneganti
    Article
  • Hepatitis C virus (HCV) infection blunts induction of hepcidin expression by bone morphogenetic protein 6 (BMP6), probably via TNF-mediated downregulation of the BMP co-receptor HJV, while BMP6 regulates a gene repertoire reminiscent of type I IFN signalling. BMP6 and related activin proteins potently block replication of HCV, hepatitis B virus and Zika virus independently of IFN.

    • Lucy A. Eddowes
    • Kinda Al-Hourani
    • Hal Drakesmith
    Article